# Nebulizer Delivery of Intranasal Scopolamine

> **NCT04999449** · PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Scopolamine
- Motion Sickness

## Interventions

- **DRUG:** Scopolamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04999449
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-05-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04999449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04999449, "Nebulizer Delivery of Intranasal Scopolamine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04999449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*